Autosomal dominant polycystic kidney disease and pioglitazone for its therapy: a comprehensive review with an emphasis on the molecular pathogenesis and pharmacological aspects
Abstract Autosomal dominant polycystic kidney disease (ADPKD) is an inherited chronic kidney disorder (CKD) that is characterized by the development of numerous fluid-filled cysts in kidneys. It is caused either due to the mutations in the PKD1 or PKD2 gene that encodes polycystin-1 and polycystin-2...
Main Authors: | Aryendu Kumar Saini, Rakesh Saini, Shubham Singh |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-12-01
|
Series: | Molecular Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s10020-020-00246-3 |
Similar Items
-
Pathogenesis and potential therapy of autosomal dominant polycystic kidney disease
by: O.O. Melnyk
Published: (2017-10-01) -
Cyst growth, polycystins, and primary cilia in autosomal dominant polycystic kidney disease
by: Seung Hun Lee, et al.
Published: (2014-06-01) -
Autosomal dominant polycystic kidney disease: an update on epidemiological and molecular aspects
by: Everton F. Alves, et al.
Published: (2015-12-01) -
Zebrafish Model as a Screen to Prevent Cyst Inflation in Autosomal Dominant Polycystic Kidney Disease
by: Inês Oliveira, et al.
Published: (2021-08-01) -
Molecular and cellular pathogenesis of autosomal dominant polycystic kidney disease
by: A.P. Bastos, et al.
Published: (2011-07-01)